This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
New Tools Will Aid Doctor-Patient Discussions on Prostate Cancer, Treatment Options
By News Staff
The D recommendation, which applies to asymptomatic men in the general U.S. population, regardless of age, does not include the use of the PSA test for surveillance after diagnosis or treatment of prostate cancer.
According to available data, 90 percent of U.S. men with PSA-detected prostate cancer are treated, and as many as five in 1,000 men who are treated surgically will die within one month of the surgery. In addition, the PSA test often produces false-positive results, which are associated with negative psychological effects and other adverse events.
In May, AAFP President Glen Stream, M.D., M.B.I., of Spokane, Wash., told AAFP News Now that when it comes to testing or not, the decision remains between individual doctors and their patients, but it needs to be done using all the information available.
"Having that discussion, and knowing the test may do more harm than good, is important," Stream said.